Hope x to Neonatal Congenital Heart

Had a chance to attend #TEIBIO - 

Transference (of knowledge Entrepreneurship ) & Innovation in Biotech .

inspirational talk on rare diseases awareness day and topics were bringing hope to paediatrics #nicu: by address solutions to Neonatal Congenital Heart #CHD ❤️and better tolerance heart transplant.

- 💡Crazy scienceco-founder Dr. Beatriz Salvador shows us how her team have found a non-invasive treatment for Congenital Diaphragmatic Hernia. 

They were able the hole in CDH by regulating the immune system. 

Have had 75%success rate and animal models have shown low toxicity.

Currently recognized as an orphan drug EU - finalize animal model trial in a non-rodent model. 

Hopes to begin clinical trials in 2025 with the esteem collaboration of Dra. Mayte Vallejo, del Instituto para la Investigación Biomédica del Hospital Universitario La Paz de Madrid (IDIPAZ) y paciente advocacy association «La vida con Hernia Diafragmática Congénita» located in Mérida, Spain.

Crazy Science & Business S.L.   
https://crazyscience.es

Rafael C. Rocha   THYTECH founded a start-up to find a solution to avoid rejection in❤️ transplant in babies. Here the team are using an infant's timus cell to avoid rejection.

https://es.linkedin.com/company/thytech

Thanks to Carlos Cosculluela Chocarro for the shout-out. @FundacionDRO AsBioMad